Positioning Statement
Latest News

BIO Ventures for Global Health

BIO Ventures for Global Health (BVGH) is a results-oriented nonprofit organization based in Seattle, Washington. BVGH was established in 2004 by the Biotechnology Innovation Organization (BIO) to engage biotechnology, pharmaceutical, and diagnostic companies in meaningful initiatives and programs to impact global health. BVGH programs fall within three categories:

  • R&D for poverty-related diseases
  • Capacity building in low- and middle-income countries
  • Access to medicines

For more information about BVGH, services offered, or current programs download the brochure.


BIO 2017: A Peek at Pavilions | Sub-Saharan Africa

(May 18, 2017) – The Biotechnology Innovation Organization (BIO) published an article highlighting the Africa Pavilion at the 2017 BIO International Convention as part of their Peek at Pavilions series. Learn about the Africa Pavilion exhibitors and the unique opportunity to "visit" 24 African countries at booth #243 at the BIO Convention in June. Click here to read more.

Cancer Crisis in Africa Prompts BVGH's New African Access Initiative

(May 17, 2017) – In a press release today, BVGH announced that it will expand its programs to address the emerging cancer crisis in Africa. The African Access Initiative (AAI) will provide affordable, sustainable access to cancer therapeutics, enhance healthcare capacity, and foster cancer research in Africa. BVGH will launch its new initiative at the BIO International Convention in San Diego on June 21, 2017. Click here to read more.

BIO Ventures for Global Health Expands Its Board to Strengthen Its Nonprofit Global Health Expertise

(March 31, 2017) – BVGH announced today that Dr. Stefan Kaufmann, Founding Director of the Max Planck Institute for Infection Biology; and Dr. Groesbeck Parham, Professor of Obstetrics and Gynecology at the University of North Carolina at Chapel Hill and Honorary Professor at the University of Zambia, global health experts, have joined its Board of Directors. Click here to read more.

Adversity on the Path to Global Drug Distribution

(March 3, 2017) – Outsourced Pharma published part two of its article series following Jennifer Dent’s path to assuming leadership of BVGH. This article describes BVGH’s fundamental approach and its focus on engaging industry to impact global health. Click here to read more.